095700.KQ
Genexine, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,835.00
+1.43%Forward multiples
Based on analyst estimates
- P/E forward
- 4.49x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 40.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.64x
- Price / sales
- 25.94x
- Price / cash flow
- -4.58x
Enterprise value
- Enterprise value
- KRW 218.0B
- EV / sales
- 43.86x
- EV / EBITDA
- 467.76x
- EV / EBIT
- -5.57x
- Market cap
- KRW 128.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026